Healthcare -
Biotechnology - NASDAQ - US
$ 18.13
6.27 %
$ 1.44 B
Market Cap
-4.2
P/E
VRDN - ACCOUNTS PAYABLE
Accounts Payable VRDN - Viridian Therapeutics, Inc.
2.24 M
LAST VALUE
-1.95%
2 YEAR CAGR
31.43%
5 YEAR CAGR
36.46%
10 YEAR CAGR